{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-23",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0597-0182",
      "generic_name": "empagliflozin and linagliptin",
      "labeler_name": "Boehringer Ingelheim Pharmaceuticals, Inc.",
      "brand_name": "Glyxambi",
      "active_ingredients": [
        {
          "name": "EMPAGLIFLOZIN",
          "strength": "10 mg/1"
        },
        {
          "name": "LINAGLIPTIN",
          "strength": "5 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0597-0182-30",
          "description": "30 TABLET, FILM COATED in 1 BOTTLE (0597-0182-30)",
          "marketing_start_date": "20150130",
          "sample": false
        },
        {
          "package_ndc": "0597-0182-39",
          "description": "30 BLISTER PACK in 1 CARTON (0597-0182-39)  / 1 TABLET, FILM COATED in 1 BLISTER PACK",
          "marketing_start_date": "20150130",
          "sample": false
        },
        {
          "package_ndc": "0597-0182-90",
          "description": "90 TABLET, FILM COATED in 1 BOTTLE (0597-0182-90)",
          "marketing_start_date": "20150130",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Boehringer Ingelheim Pharmaceuticals, Inc."
        ],
        "rxcui": [
          "1602109",
          "1602115",
          "1602118",
          "1602120"
        ],
        "spl_set_id": [
          "ddbab689-f76c-488c-9613-4168d41dd730"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000187059",
          "N0000187058",
          "N0000175912",
          "N0000175913"
        ],
        "pharm_class_epc": [
          "Sodium-Glucose Cotransporter 2 Inhibitor [EPC]",
          "Dipeptidyl Peptidase 4 Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "Sodium-Glucose Transporter 2 Inhibitors [MoA]",
          "Dipeptidyl Peptidase 4 Inhibitors [MoA]"
        ],
        "unii": [
          "HDC1R2M35U",
          "3X29ZEJ4R2"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "TABLET, FILM COATED",
      "spl_id": "16f275d5-7526-4e7a-8776-665a9a6ae37a",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20150130",
      "product_id": "0597-0182_16f275d5-7526-4e7a-8776-665a9a6ae37a",
      "application_number": "NDA206073",
      "brand_name_base": "Glyxambi",
      "pharm_class": [
        "Dipeptidyl Peptidase 4 Inhibitor [EPC]",
        "Dipeptidyl Peptidase 4 Inhibitors [MoA]",
        "Sodium-Glucose Cotransporter 2 Inhibitor [EPC]",
        "Sodium-Glucose Transporter 2 Inhibitors [MoA]"
      ]
    }
  ]
}